A Randomized Phase II Trial of Cytotoxic Chemotherapy With or Without Epigenetic Priming in Patients With Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 May 2013
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Docetaxel; Entinostat; Gemcitabine; Irinotecan; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 May 2013 New trial record